Press release

IQVIA’s OCE Technology Platform Selected by Salehiya Medical to Enhance Customer Experience in Saudi Arabia

Sponsored by Businesswire

(NYSE:IQV) today announced that Salehiya
, a leading Saudi Arabian healthcare distribution company,
has selected IQVIA Technologies’ Orchestrated
Customer Engagement (OCE)
platform for deployment within its medical
supplies division to harmonize customer interactions across multiple
marketing channels and optimize performance.

OCE combines the efficiency of automated multichannel marketing, the
humanity of traditional sales, and the power of next-generation
technology to improve and deepen customer engagement enabling companies
to make more effective commercial decisions.

“The OCE platform offers us an unparalleled opportunity,” said Jalil
Juha, chief executive officer of Salehiya. “By streamlining
communications and coordinating customer interactions, we will be able
to build trust-based relationships with clients and increase the
effectiveness of our engagements with healthcare professionals.”

Salehiya will use the OCE platform’s sales persona solution to remove
the walls between sales and marketing and use integrated software
systems to collect and analyze customer data, align messaging with
customer needs and coordinate message delivery across multiple channels.

“We are looking forward to this strategic collaboration with Salehiya
Medical, our first Saudi Arabian client for OCE,” said Amit Sadana,
senior vice president & general manager, Africa, Middle East & South
Asia, IQVIA. “Life sciences companies can work differently with OCE to
streamline processes, bolster customer relationships, and drive greater
client understanding to better anticipate and respond to market changes.”

About Salehiya

Salehiya is a leading Saudi Arabian company involved in the distribution
of pharmaceuticals, medical and laboratory equipment, diagnostics,
medical disposables and hospital and consumer supplies.


IQVIA (NYSE:IQV) is a leading global provider of advanced analytics,
technology solutions and contract research services to the life sciences
industry. Formed through the merger of IMS Health and Quintiles, IQVIA
applies human data science — leveraging the analytic rigor and clarity
of data science to the ever-expanding scope of human science — to enable
companies to reimagine and develop new approaches to clinical
development and commercialization, speed innovation and accelerate
improvements in healthcare outcomes. Powered by the IQVIA CORE, IQVIA
delivers unique and actionable insights at the intersection of
large-scale analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With more than 58,000
employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The
company uses a wide variety of privacy-enhancing technologies and
safeguards to protect individual privacy while generating and analyzing
information on a scale that helps healthcare stakeholders identify
disease patterns and correlate with the precise treatment path and
therapy needed for better outcomes. IQVIA’s insights and execution
capabilities help biotech, medical device and pharmaceutical companies,
medical researchers, government agencies, payers and other healthcare
stakeholders tap into a deeper understanding of diseases, human
behaviors and scientific advances, in an effort to advance their path
toward cures. To learn more, visit

here to subscribe to Mobile Alerts for IQVIA.